Anabolic-androgenic steroids (AAS) increase sensitivity to uncertainty by inhibition of dopamine D1 and D2 receptors
Anabolic-androgenic steroid abuse is implicated in maladaptive behaviors such as impaired cognition in humans. In a rat model, our lab has shown that testosterone decreases preference for a large/uncertain reward in probability discounting. Other studies have shown that androgens decrease dopamine D1 and D2 receptors in the nucleus accumbens shell, a region important for decision-making behavior in probability discounting. Thus, we attempted to restore selection of the large/uncertain reward in testosterone-treated rats by administering the D2 receptor agonist quinpirole or the D1 receptor agonist SKF81297 and testing probability discounting.
Adolescent male Long-Evans rats were treated chronically with high-dose testosterone (7.5 mg/kg) or vehicle (13% cyclodextrin in water), and tested for probability discounting after injections of saline, 0.1 and 0.5 mg/kg of quinpirole or SKF81297. Rats chose between a small/certain reward (1 sugar pellet, 100% probability) and a large/uncertain reward (4 pellets, decreasing probability: 100, 75, 50, 25, 0%).
Testosterone-treated rats selected the large/uncertain reward significantly less than vehicle-treated controls after saline injection. However, acute injection with 0.1 mg/kg quinpirole increased large/uncertain reward preference in testosterone-treated rats only, indicated by a testosterone × quinpirole interaction. At 0.5 mg/kg, quinpirole increased large/uncertain reward preference in all rats. Acute injection with SKF81297 at 0.1 or 0.5 mg/kg rescued large/uncertain reward preference in testosterone-treated rats by eliminating the difference between groups.
It appears that altered probability discounting behavior in testosterone-treated rats is due to both decreased D1 and D2 receptor function.
KeywordsAnabolic agents Dopamine Decision making Operant behavior Food reward
This work was funded by NIH R01-DA029613 to RIW.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- Beckstead RM, Domesick VB, Nauta WJ (1993) Efferent connections of the substantia nigra and ventral tegmental area in the rat. In: Neuroanatomy. Birkhäuser, Boston, pp 449–475Google Scholar
- Boulougouris V, Castañé A, Robbins TW (2009) Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior. Psychopharmacology 202(4):611–620. https://doi.org/10.1007/s00213-008-1341-2 CrossRefPubMedGoogle Scholar
- Eagle DM, Noschang C, d’Angelo LS, Noble CA, Day JO, Dongelmans ML, Theobald DE, Mar AC, Urcelay GP, Morein-Zamir S, Robbins TW (2014) The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD. Behav Brain Res 264:207–229. https://doi.org/10.1016/j.bbr.2013.12.040 CrossRefPubMedPubMedCentralGoogle Scholar
- Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE (2013) Monitoring the future national survey results on drug use: 2012 overview, key findings on adolescent drug use. Institute for Social Research, The University of Michigan, Ann ArborGoogle Scholar
- Peters KD, Wood RI (2004) Androgen dependence in hamsters: overdose, tolerance, and potential opioidergic mechanisms. Neuroscience 130(4):971–981. https://doi.org/10.1016/j.neuroscience.2004.09.063 CrossRefGoogle Scholar
- WADA (2012) Anti-doping testing figures report. www.wada-ama.org